107 related articles for article (PubMed ID: 19200035)
21. Structure analysis of activity-dependent neurotrophic factor 9 by circular dichroism and sedimentation equilibrium.
Arakawa T; Niikura T; Tajima H; Arisaka F; Kita Y
J Mol Neurosci; 2007; 33(3):262-7. PubMed ID: 17952635
[TBL] [Abstract][Full Text] [Related]
22. Advances in characterization of neuroprotective peptide, humanin.
Arakawa T; Hirano A; Shiraki K; Niikura T; Kita Y
Curr Med Chem; 2011; 18(36):5554-63. PubMed ID: 22172065
[TBL] [Abstract][Full Text] [Related]
23. Interaction structure of the complex between neuroprotective factor humanin and Alzheimer's β-amyloid peptide revealed by affinity mass spectrometry and molecular modeling.
Maftei M; Tian X; Manea M; Exner TE; Schwanzar D; von Arnim CA; Przybylski M
J Pept Sci; 2012 Jun; 18(6):373-82. PubMed ID: 22522311
[TBL] [Abstract][Full Text] [Related]
24. Short neuroprotective peptides, ADNF9 and NAP, are structurally disordered and monomeric in PBS.
Arakawa T; Niikura T; Arisaka F; Kita Y
Int J Biol Macromol; 2009 Jul; 45(1):8-11. PubMed ID: 19447252
[TBL] [Abstract][Full Text] [Related]
25. Identification of essential amino acids in Humanin, a neuroprotective factor against Alzheimer's disease-relevant insults.
Yamagishi Y; Hashimoto Y; Niikura T; Nishimoto I
Peptides; 2003 Apr; 24(4):585-95. PubMed ID: 12860203
[TBL] [Abstract][Full Text] [Related]
26. Conformation and self-association of human recombinant transforming growth factor-beta3 in aqueous solutions.
Pellaud J; Schote U; Arvinte T; Seelig J
J Biol Chem; 1999 Mar; 274(12):7699-704. PubMed ID: 10075659
[TBL] [Abstract][Full Text] [Related]
27. Humanin decreases mitochondrial membrane permeability by inhibiting the membrane association and oligomerization of Bax and Bid proteins.
Ma ZW; Liu DX
Acta Pharmacol Sin; 2018 Jun; 39(6):1012-1021. PubMed ID: 29265109
[TBL] [Abstract][Full Text] [Related]
28. Humanins, the neuroprotective and cytoprotective peptides with antiapoptotic and anti-inflammatory properties.
Zapała B; Kaczyński Ł; Kieć-Wilk B; Staszel T; Knapp A; Thoresen GH; Wybrańska I; Dembińska-Kieć A
Pharmacol Rep; 2010; 62(5):767-77. PubMed ID: 21098860
[TBL] [Abstract][Full Text] [Related]
29. The effects of humanin and its analogues on male germ cell apoptosis induced by chemotherapeutic drugs.
Jia Y; Ohanyan A; Lue YH; Swerdloff RS; Liu PY; Cohen P; Wang C
Apoptosis; 2015 Apr; 20(4):551-61. PubMed ID: 25666707
[TBL] [Abstract][Full Text] [Related]
30. Humanin rescues cortical neurons from prion-peptide-induced apoptosis.
Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Pillot T
Mol Cell Neurosci; 2004 Jan; 25(1):95-102. PubMed ID: 14962743
[TBL] [Abstract][Full Text] [Related]
31. S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.
Zhang W; Du Y; Bai M; Xi Y; Li Z; Miao J
J Pept Sci; 2013 Mar; 19(3):159-65. PubMed ID: 23349038
[TBL] [Abstract][Full Text] [Related]
32. The complex structure transition of Humanin peptides by sodium dodecylsulfate and trifluoroethanol.
Kita Y; Niikura T; Arisaka F; Arakawa T
Protein Pept Lett; 2008; 15(5):510-5. PubMed ID: 18537742
[TBL] [Abstract][Full Text] [Related]
33. Humanin: after the discovery.
Niikura T; Chiba T; Aiso S; Matsuoka M; Nishimoto I
Mol Neurobiol; 2004 Dec; 30(3):327-40. PubMed ID: 15655255
[TBL] [Abstract][Full Text] [Related]
34. Involvement of tyrosine kinases and STAT3 in Humanin-mediated neuroprotection.
Hashimoto Y; Suzuki H; Aiso S; Niikura T; Nishimoto I; Matsuoka M
Life Sci; 2005 Oct; 77(24):3092-104. PubMed ID: 16005025
[TBL] [Abstract][Full Text] [Related]
35. Humanin inhibits cell death of serum-deprived PC12h cells.
Kariya S; Takahashi N; Ooba N; Kawahara M; Nakayama H; Ueno S
Neuroreport; 2002 May; 13(6):903-7. PubMed ID: 11997711
[TBL] [Abstract][Full Text] [Related]
36. [Humanin and its derivatives as peptides with potential antiapoptotic and confirmed neuroprotective activities].
Zapała B; Staszel T; Kieć-Wilk B; Polus A; Knapp A; Wybrańska I; Kaczyński Ł; Dembińska-Kieć A
Przegl Lek; 2011; 68(7):372-7. PubMed ID: 22010475
[TBL] [Abstract][Full Text] [Related]
37. Development of a femtomolar-acting humanin derivative named colivelin by attaching activity-dependent neurotrophic factor to its N terminus: characterization of colivelin-mediated neuroprotection against Alzheimer's disease-relevant insults in vitro and in vivo.
Chiba T; Yamada M; Hashimoto Y; Sato M; Sasabe J; Kita Y; Terashita K; Aiso S; Nishimoto I; Matsuoka M
J Neurosci; 2005 Nov; 25(44):10252-61. PubMed ID: 16267233
[TBL] [Abstract][Full Text] [Related]
38. Humanin protects neurons against apoptosis induced by Abeta31-35 through suppression of intrinsic pathway.
Li LM; Zhang Y; Qiao JT; Zhang C
Sheng Li Xue Bao; 2010 Apr; 62(2):93-100. PubMed ID: 20401442
[TBL] [Abstract][Full Text] [Related]
39. Humanin peptides block calcium influx of rat hippocampal neurons by altering fibrogenesis of Abeta(1-40).
Zou P; Ding Y; Sha Y; Hu B; Nie S
Peptides; 2003 May; 24(5):679-85. PubMed ID: 12895653
[TBL] [Abstract][Full Text] [Related]
40. Evidence for in vivo production of Humanin peptide, a neuroprotective factor against Alzheimer's disease-related insults.
Tajima H; Niikura T; Hashimoto Y; Ito Y; Kita Y; Terashita K; Yamazaki K; Koto A; Aiso S; Nishimoto I
Neurosci Lett; 2002 May; 324(3):227-31. PubMed ID: 12009529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
